Quick Guide to Rare Disease

With a patient-first mindset, we deliver tailored services that support the unique needs of individuals, families, and clinical sites involved in rare disease research. Our specialized expertise in the complexities of rare disease trials enables us to craft customized strategies that not only enhance operational efficiency but also increase the potential for transformative breakthroughs.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

03/13/2025

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology

RALEIGH, N.C.; Mar. 13, 2025 – Caidya, a leading global,...

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Skip to toolbar